# 2025-18082: FDA Downgrades Hepatitis B Tests to Faster Approval Category

2025-18082, Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2025-09-18, effective 2025-10-20 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-18082
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-18082
- Title: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 44969
- Published: 2025-09-18
- Effective: 2025-10-20
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

FDA Downgrades Hepatitis B Tests to Faster Approval Category

## Summary

The FDA is changing the rules for certain hepatitis B test devices, moving them from a strict category (Class III) to a less strict one (Class II) with special safety rules. This affects companies making HBV antigen, antibody, and nucleic acid tests, who now need to follow new guidelines and submit notifications before selling. These changes help speed up access to safe, reliable hepatitis B tests without extra costs or delays.

## Abstract

The Food and Drug Administration (FDA) is issuing a final order reclassifying qualitative hepatitis B virus (HBV) antigen assays (product code LOM), HBV antibody assays (product code LOM), and quantitative HBV nucleic acid-based assays (product code MKT), all of which are postamendments class III devices, into class II (special controls), subject to premarket notification. FDA is also establishing the special controls that are necessary to provide a reasonable assurance of safety and effectiveness of these device types.

## Effects PRIA read

- Manufacturers Must File Premarket Notices: benefit, medium. If you make hepatitis B test devices, the FDA moved certain tests into class II and says you must follow new special controls and submit a premarket notification before marketing. This applies to qualitative HBV antigen assays (product code LOM), HBV antibody assays (product code LOM), and quantita…
- Easier Access to Hepatitis B Tests: benefit, medium. If you need a hepatitis B test, the FDA reclassified certain HBV antigen, antibody, and nucleic acid tests to class II with special controls and now allows them to be marketed after premarket notification. This change is meant to help speed access to safe, reliable hepatitis B tests for patients be…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-18082 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/18/2025-18082/microbiology-devices-reclassification-of-antigen-antibody-and-nucleic-acid-based-hepatitis-b-virus)
- [2025-18082 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-18/pdf/2025-18082.pdf)

## Related
- [Previous: 2025-18080, Radiological Health Regulations; Technical Amendments](https://policyrisk.com/federal-register/2025-18080)
- [Next: 2025-18083, Airworthiness Directives; Airbus Helicopters](https://policyrisk.com/federal-register/2025-18083)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-18082 (as of 2026-06-11).
